HEALTH

New Lo Loestrin Fe gets FDA approval

BY Alaric DeArment

ARDEE, Ireland The Food and Drug Administration has approved a new contraceptive from Warner Chilcott, the drug maker said Friday.

 

The company said it plans to launch Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) early next year. The company said the contraceptive contains the lowest dosage of estrogen — 10 micrograms — of any oral contraceptive currently available in the U.S. market.

 

 

“We are excited about the approval of Lo Loestrin Fe, which complements our women’s healthcare franchise and expands the product offerings in our branded oral contraceptive portfolio,” president and CEO Roger Boissonneault said in a statement.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Transcript Pharmacy receives ACHC accreditation

BY Allison Cerra

JACKSON, Miss. A pharmacy that specializes in serving patients with chronic medical conditions has received accreditation status from the Accreditation Commission for Health Care for specialty pharmacy services.

Transcript Pharmacy said Wednesday it was awarded ACHC accreditation, a voluntary activity where healthcare organizations submit to peer review of their internal policies, processes and patient care delivery against national standards. Transcript recently was involved in a year-long study conducted by Virginia Commonwealth University, which showed that through personalized communication with each patient, Transcript improved compliance.

“This recognition demonstrates that the level of care and quality of services we offer bring significant benefits to the patients that we serve,” said company president Cliff Osbon.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

NACDS addresses medication adherence at Senate Health Fair

BY Allison Cerra

WASHINGTON The National Association of Chain Drug Stores emphasized the importance of pharmacy-patient interaction at this year’s Senate Health Fair, held last week in Washington, D.C.

The chain pharmacy lobby hosted an exhibit at the fair that emphasized the importance of medication adherence. More than 200 Senate staffers visited the NACDS booth over the two-day event, NACDS said. Pharmacists from NACDS members Kerr Drug Supervalu pharmacies counseled staffers on proper medication use, answered questions on health issues and provided advice on predispositions to chronic diseases.

“This is the first time NACDS has been invited to participate in the Senate Health Fair, clearly demonstrating the valuable role that pharmacy plays in the healthcare delivery system,” said NACDS president and CEO Steve Anderson. “Pharmacy is the face of neighborhood health care, and NACDS is committed to showcasing this value.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?